≥65岁股骨颈骨折:全髋与半髋置换的系统评价与Meta分析
该系统评价与Meta分析纳入18项RCT共2908例≥65岁移位性股骨颈骨折患者,比较全髋关节置换(THA)与半髋置换。THA未增加翻修或死亡风险,但脱位风险更高,Harris髋关节评分(HHS)差异未达临床重要阈值,且手术时间更长、出血更多。
要点
- THA与半髋置换的翻修风险(RR 1.10)和全因死亡率(RR 0.99)无差异。
- THA脱位风险更高(RR 0.57),髋相关并发症复合终点无差异。
- HHS均差5分未达10分临床重要阈值,半髋手术时间短31分钟、出血少115mL。
核心结论
- 对于65岁及以上移位性股骨颈骨折患者,THA相比半髋置换无临床重要的功能获益,且增加脱位风险。
- 半髋置换可由多数值班骨科医生完成,而THA常需专科医生,因此半髋置换是多数老年患者的更好选择。
研究设计与样本
- 遵循PRISMA指南,方案注册于PROSPERO(CRD42022344531),检索Medline、Embase、Cochrane Library和Web of Science(2000年1月至2025年10月)。
- 纳入18项直接比较THA与半髋置换术后结局的RCT,共2908例参与者(平均年龄78±8岁,女性69%)。
- 排除来自同一患者队列的重复报告,采用Cochrane偏倚风险评估工具,总体偏倚风险为中至低。
- 采用逆方差随机效应模型(p≤0.1或I2≥50%)或固定效应模型合并效应量,GRADE框架评估证据确定性。
主要发现
- THA与半髋置换的翻修风险(RR 1.10 [95%CI 0.82至1.49];p=0.52)和全因死亡率(RR 0.99 [95%CI 0.81至1.22];p=0.54)无差异。
- 髋相关并发症复合终点无差异(RR 0.89 [95%CI 0.74至1.08];p=0.25),但THA脱位风险更高(RR 0.57 [95%CI 0.37至0.89];p=0.01)。
- HHS均差5分(95%CI 3至7;p<0.001),未达10分的最小临床重要差异。
- 半髋置换手术时间更短(均差31分钟 [95%CI -44.13至-18.81];p<0.001),出血更少(均差115 mL [95%CI -165.87至-64.15];p<0.001)。
- HHS(I2=76%)、手术时间(I2=98%)和出血(I2=98%)存在显著异质性,其余结局异质性低(I2≤41%)。
关键数值与推荐
- HHS范围0至100分,分数越高疼痛越轻、功能越好,最小临床重要差异取10分。
- 髋相关并发症复合终点包括脱位、假体周围骨折、植入物失败(松动或下沉)和外展机制失败。
- GRADE证据确定性:翻修风险、死亡率、髋相关并发症和脱位为中等;功能结局(HHS)为低。
- 敏感性分析(排除高偏倚风险试验、仅意向性治疗分析、替代效应模型)证实结果稳健。
临床怎么用
- 对于≥65岁移位性股骨颈骨折,半髋置换可作为多数老年患者的首选,因THA无临床重要功能优势且脱位风险更高。
- THA需权衡脱位风险,尤其在不具备专科医生条件时,半髋置换更易由值班骨科医生完成。
- 未来研究应评估≥10年长期结局,并比较双动THA与双极半髋置换以明确现代技术能否缩小脱位差距。
局限性
- HHS、手术时间和出血存在显著异质性(I2分别为76%、98%、98%)。
- 功能结局(HHS)的证据确定性为低。
- 未报告长期(≥10年)结局,仍需未来研究评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple meta-analyses have compared THA with hemiarthroplasty for displaced femoral neck fractures in patients over 65 years of age; however, clinical equipoise persists. We posit that this persistent uncertainty does not reflect a paucity of evidence but rather stems from critical methodological limitations in prior syntheses-including incomplete evidence searches, inadvertent inclusion of duplicate outcome data from overlapping patient cohorts, and inappropriate pooling of RCTs with nonrandomized or retrospective studies. An updated, rigorously conducted meta-analysis of RCTs-designed to rectify these flaws-is therefore needed to inform evidence-based clinical decision-making. QUESTIONS/PURPOSES: (1) Is THA associated with a reduced risk of revision surgery and death compared with hemiarthroplasty? (2) Is THA associated with fewer hip-related complications-including dislocation, periprosthetic fracture, and infection? (3) Does THA result in clinically important improvements in functional outcomes as measured by validated hip scores (such as the Harris hip score [HHS])? (4) Does hemiarthroplasty result in reduced operative time and estimated blood loss? METHODS: Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed, and the study protocol was published online at PROSPERO under registration number CRD42022344531. We searched the Medline, Embase, Cochrane Library, and Web of Science databases for papers published between January 2000 and October 2025, and the searches were performed from August 2024 to October 2025. We included RCTs that directly compared the postoperative outcomes of the two prosthesis types. Two independent reviewers performed title and abstract screening, full-text assessment, and data extraction. To eliminate duplication and inflated precision, we identified and excluded all reports deriving from the same patient cohort-including secondary publications, subgroup analyses, and extended follow-up reports. A systematic search retrieved 4016 records. After assessment for eligibility against prespecified criteria, 18 RCTs involving 2908 participants (mean ± SD age 78 ± 8 years; 69% female patients) were included in the meta-analysis. Baseline age and sex did not differ between THA and hemiarthroplasty groups. Risk of bias was evaluated using the Cochrane Risk of Bias tool for RCTs, revealing an overall moderate to low risk of bias. Pooled effect estimates were computed using inverse-variance random-effects models (p ≤ 0.1 or I2 ≥ 50%); otherwise, a fixed-effects model was used. Heterogeneity was quantified using the I2 statistic. Substantial heterogeneity was observed for the HHS (I2 = 76%), operative time (I2 = 98%), and blood loss (I2 = 98%), for which random-effects models were used. Heterogeneity was low for all other outcomes (I2 ≤ 41%), and fixed-effects models were applied. Publication bias was evaluated using funnel plots and the Egger test, which did not suggest publication bias. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework, which suggested moderate certainty of evidence for revision risk, mortality, hip-related complications, and dislocation and low for functional outcomes (HHS). For the main outcomes score we used the HHS (range 0 to 100, with higher scores representing less pain and better function; the minimum clinically important difference was taken to be 10 points). The composite endpoint of hip-related complications included dislocation, periprosthetic fracture, implant failure (loosening or subsidence), and abductor mechanism failure-events directly related to the arthroplasty procedure and of comparable clinical importance. RESULTS: Compared with hemiarthroplasty, THA was not associated with an increased risk of revision surgery (risk ratio [RR] 1.10 [95% confidence interval (CI) 0.82 to 1.49]; p = 0.52) or all-cause mortality (RR 0.99 [95% CI 0.81 to 1.22]; p = 0.54). No difference was observed in the composite endpoint of hip-related complications (RR 0.89 [95% CI 0.74 to 1.08]; p = 0.25). However, THA was associated with a higher risk of dislocation (RR 0.57 [95% CI 0.37 to 0.89]; p = 0.01). We found no clinically important difference in HHS between patients undergoing THA and those undergoing hemiarthroplasty (mean difference 5 points [95% CI 3 to 7]; p < 0.001). Operative time was shorter with hemiarthroplasty (mean difference 31 minutes [95% CI -44.13 to -18.81]; p < 0.001) and blood loss was less (mean difference 115 mL [95% CI -165.87 to -64.15]; p < 0.001) than for those in the THA group. Sensitivity analyses-excluding high risk-of-bias trials, restricting to intention-to-treat analyses, and applying alternative effect models-confirmed the consistency and robustness of these results. CONCLUSION: For patients age 65 years or older with displaced femoral neck fractures, THA offers no clinically important functional benefit over hemiarthroplasty and increases the risk of dislocation. Hemiarthroplasty can be performed by most call-taking orthopaedic surgeons, whereas THA often requires a specialist; therefore, hemiarthroplasty is the better choice for most older patients. Future research should assess long-term outcomes (≥ 10 years) and compare dual-mobility THA with bipolar hemiarthroplasty to determine whether modern techniques narrow the dislocation gap and how late complications alter the risk-benefit balance. LEVEL OF EVIDENCE: Level I, therapeutic study.
引用
- Cao Z, Niu C, Liu W, et al. Does THA Offer Clinically Important Benefits Over Hemiarthroplasty for Femoral Neck Fracture in Patients Age 65 Years or Older? A Systematic Review and Meta-analysis. Clin Orthop Relat Res. 2026. PMID: 42475480. doi:10.1097/CORR.0000000000004068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。